Related LncRNAs
ID	lncRNA Name	Disease	Method	Sample	Expression pattern	Dysfunction type	Description	PMID	Source
EL0023	AC006050.3-003	lung squamous cell carcinoma	N/A	N/A	N/A	N/A	The expression of lncRNA AC006050.3-003 was significantly lower in PR samples compared to the PD samples in another 60 lung squamous cell carcinoma patients. Receiver operating characteristic curve analysis revealed that lncRNA AC006050.3-003 was a valuable biomarker for differentiating PR patients from PD patients with an area under the curve of 0.887 (95% confidence interval 0.779, 0.954).	25250788	LncRNADisease
EL0686	LINC01133	lung squamous cell carcinoma	microarray, qPCR, knockdown etc.	NSCLC tissue, cell lines (H1703)	up-regulated	N/A	LSCC patients with higher expression level of LINC01133 had shorter survival time. LINC01133 is upregulated in lung squamous cell cancer and predicts survival	25908174	LncRNADisease Lnc2Cancer
EL1007	NPTN-IT1	lung squamous cell carcinoma	qPCR, Western blot, in vitro knockdown, RIP etc.	LSCC tissue, cell lines (QSG-7701, LO2, SMMC-7721 etc.)	down-regulated	expression	In this study, we found that the lncRNA Low Expression in Tumor (lncRNA-LET) was generally downregulated in hepatocellular carcinomas, colorectal cancers, and squamous-cell lung carcinomas.	23395002	LncRNADisease Lnc2Cancer
EL1236	SOX2-OT	lung squamous cell carcinoma	qPCR, Western blot, knockdown, RIP etc.	cell lines (A549, HCC827, SK-MES-1, NCI-H1299 etc.)	up-regulated	N/A	Sox2ot exprssion in lung cancer is significantly higher and promotes cancer cell proliferation. Sox2ot plays an important role in regulating lung cancer cell proliferation, and may represent a novel prognostic indicator for the disease.	24927902	Lnc2Cancer